Increased Expression of TGF-β1 in Correlation with Liver Fibrosis during Echinococcus granulosus Infection in Mice |
Liu, Yumei
(State Key Laboratory of Xinjiang Major Diseases Research Incubation Base (2010DS890294) and Xinjiang Key Laboratory of Echinococcosis, First Affiliated Hospital of Xinjiang Medical University)
Abudounnasier, Gulizhaer (State Key Laboratory of Xinjiang Major Diseases Research Incubation Base (2010DS890294) and Xinjiang Key Laboratory of Echinococcosis, First Affiliated Hospital of Xinjiang Medical University) Zhang, Taochun (College of Basic Medical Sciences of Xinjiang Medical University) Liu, Xuelei (College of Basic Medical Sciences of Xinjiang Medical University) Wang, Qian (State Key Laboratory of Xinjiang Major Diseases Research Incubation Base (2010DS890294) and Xinjiang Key Laboratory of Echinococcosis, First Affiliated Hospital of Xinjiang Medical University) Yan, Yi (College of Basic Medical Sciences of Xinjiang Medical University) Ding, Jianbing (College of Basic Medical Sciences of Xinjiang Medical University) Wen, Hao (State Key Laboratory of Xinjiang Major Diseases Research Incubation Base (2010DS890294) and Xinjiang Key Laboratory of Echinococcosis, First Affiliated Hospital of Xinjiang Medical University) Yimiti, Delixiati (College of Basic Medical Sciences of Xinjiang Medical University) Ma, Xiumin (State Key Laboratory of Xinjiang Major Diseases Research Incubation Base (2010DS890294) and Xinjiang Key Laboratory of Echinococcosis, First Affiliated Hospital of Xinjiang Medical University) |
1 | Herbert DR, Orekov T, Perkins C, Finkelman FD. IL-10 and TGF- redundantly protect against severe liver injury and mortality during acute schistosomiasis. J Immunol 2008; 181: 7214-7220. DOI |
2 | Liu X, Hu H, Yin JQ. Therapeutic strategies against TGF- signaling pathway in hepatic fibrosis. Liver Int 2006; 26: 8-22. DOI |
3 | Breitkopf K, Lahme B, Tag CG, Gressner AM. Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture. Hepatology 2001; 33: 387-396. DOI |
4 | Ray K. Liver: hepatic stellate cells hold the key to liver fibrosis. Nat Rev Gastroenterol Hepatol 2014; 11: 74. |
5 | Wen H, Wulamu M, Wang H. The echinococcosis learning tutorial. Xinjiang, China. Xinjiang People's Publishing House. 2009, Vol. 7, pp. 57-63 (in Chinese). |
6 | Leggatt GR, McManus DP. Sequence homology between two immunodiagnostic fusion proteins from Echinococcus multilocularis. Int J Parasitol 1992; 22: 831-833. DOI |
7 | Ito A. Introduction of ongoing research projects on echinococcosis at Asahikawa Medical College and some comments on the surveillance, prevention and control of alveolar echinococcosis in Japan. Hokkaido Igaku Zasshi 2001; 76: 3-8. |
8 | Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010; 7: 425-436. DOI |
9 | Gorelik L, Flavell RA. Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2002; 2: 46-53. DOI |
10 | Kocabayoglu P, Friedman SL. Cellular basis of hepatic fibrosis and its role in inflammation and cancer. Front Biosci (Schol Ed) 2013; 5: 217-230. |
11 | Tsolaki E, Athanasiou E, Gounari E, Zogas N, Siotou E, Yiangou M, Anagnostopoulos A, Yannaki E. Hematopoietic stem cells and liver regeneration: differentially acting hematopoietic stem cell mobilization agents reverse induced chronic liver injury. Blood Cells Mol Dis 2014; 53: 124-132. DOI |
12 | Le Bousse-Kerdiles MC, Martyre MC, Samson M. Cellular and molecular mechanisms underlying bone marrow and liver fibrosis: a review. Eur Cytokine Netw 2008; 19: 69-80. |
13 | Hu X, Rui W, Wu C, He S, Jiang J, Zhang X, Yang Y. Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-/Smad signaling. J Gastroenterol Hepatol 2014; 29: 1284-1291. DOI |
14 | Zhai W, Wang T, Zhou X. The diagnosis of chronic hepatitis, grading and staging. Chinese Digest Magazine 1996; 5: 277. |
15 | Gressner OA, Rizk MS, Kovalenko E, Weiskirchen R, Gressner AM. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go? J Gastroenterol Hepatol 2008; 23: 1024-1035. DOI |
16 | Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008; 88: 125-172. DOI |
17 | Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-218. DOI |
18 | Baker RJ, Fischer JE. Mastery of Surgery, 4th ed. Philadelphia, USA. Lippincott Williams and Willkins Inc. 2001, pp 1082-1099. |
19 | Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, Wynn TA. Immunopathology of schistosomiasis. Immunol Cell Biol 2007; 85: 148-154. DOI |
20 | Dong C. Th17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8: 337-348. DOI |
21 | Martin-Martin N, Slattery C, McMorrow T, Ryan MP. TGF- mediates sirolimus and cyclosporine A-induced alteration of barrier function in renal epithelial cells via a noncanonical ERK 1/2 signaling pathway. Am J Physiol Renal Physiol 2011; 301:1281-1292. |